Publications

President Trump has announced his intention to regulate U.S. drug prices. But the arguments in favor of doing so are wrong. Price controls reduce development of new treatments and cures, and hurt U.S. biopharmaceutical competitiveness.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

President Trump’s executive order takes aim at nuclear regulations, but without broader support for innovation, development, and scale-up, America’s nuclear ambitions will remain stuck on the launchpad.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

Canadian firms are underinvesting in productivity-enhancing capital such as machinery, software, and advanced technologies. Without targeted reforms to boost investment and improve data collection, Canada risks falling further behind in global competitiveness and economic growth.

A recent working paper finds that management quality plays a pivotal role in determining whether firms expand, contract, acquire, or shut down.

Microgravity could be the next big breakthrough in drug development, but only if policymakers act now to turn space-based research from potential into progress.

Mexico’s cloud localization rules undermine U.S. tech leadership by disadvantaging American providers and creating openings for Chinese firms. These restrictions weaken U.S. competitiveness in a key regional market.

Japan’s self-reporting rules impose costly, open-ended compliance obligations that apply almost exclusively to large U.S. tech firms. This approach reduces their strategic flexibility and operational scalability, weakening U.S. technology leadership in Asia’s digital markets.

Thailand’s proposed conduct restrictions target U.S. technology firms through scale-based thresholds and impose structural limits on how they operate core platform services. These rules weaken the foundations of U.S. technology leadership by increasing regulatory risk, reducing scalability, and accelerating policy fragmentation across Southeast Asia.